Stay updated on CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Sign up to get notified when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.

Latest updates to the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page
- Check6 days agoChange DetectedA new revision entry v3.6.5 was added to the record history, indicating an update to the page’s version history. The previous v3.6.4 entry was removed from the history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedA new revision entry (v3.6.4) was added to the study record history, and the previous revision (v3.6.3) was removed. This reflects an administrative update to the record rather than changes to the study data.SummaryDifference0.1%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedA new revision entry v3.6.3 has been added to the record history, indicating a site-wide interface update that supersedes the prior v3.6.2 revision. This reflects maintenance or UI changes rather than alterations to trial data.SummaryDifference0.1%

- Check48 days agoChange DetectedAn additional revision entry (v3.6.2) is added to the history, indicating an update to the study record. The older revision (v3.6.0) is removed from the history log.SummaryDifference0.1%

- Check63 days agoChange DetectedThe study's recruitment status is updated to 'No longer looking for participants', indicating enrollment closed. The record also includes a new revision v3.6.0 and shows the prior revision v3.5.5 has been removed.SummaryDifference0.5%

- Check70 days agoChange DetectedThe study record history shows a new revision v3.5.5, replacing the previous v3.5.4, indicating an update to the page's revision metadata.SummaryDifference0.1%

Stay in the know with updates to CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTLA4-NF, Nivolumab, Radiation in Metastatic Malignancies Clinical Trial page.